NCT00003407 2023-02-02
Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML
Rush University Medical Center
Phase 2 Withdrawn
Rush University Medical Center
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC